Dr Audrey Dubourg, product manager, and Ayisha I. A. Malik, content marketing manager CN Bio, discuss how to effectively adopt and leverage Organ-on-a-chip to drive more effective drug development.
ProFound Therapeutics has announced a four-year collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease leveraging its ProFoundry Platform.
Enhanced Genomics, a biotechnology company, has announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.
INTEGRA Biosciences’ liquid handling solutions and pipette automation software are helping 3T Biosciences to enhance the reproducibility and productivity of its pipetting workflows, accelerating the discovery of novel cancer targets and therapeutics.
Despite its growing threat to global health, research aimed at tackling antimicrobial resistance (AMR) has been constrained for many years, most likely due to the rapid evolution of resistance in pathogens, regulatory and policy barriers.
CN Bio has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS).
Shift Bioscience, a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the publication of new research identifying a novel, single-gene target for cellular rejuvenation.
Thermo Fisher Scientific has announced the launch of the Thermo Scientific Orbitrap Astral Zoom mass spectrometer (MS) and the Thermo Scientific Orbitrap Excedion Pro mass spectrometer (MS) to help push the boundaries of scientific discovery.
A large-scale international study involving researchers from the Drug Safety Research Unit (DSRU), UK, highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barré syndrome (GBS).
Medicines Discovery Catapult (MDC) and the Francis Crick Institute have announced a new strategic partnership to support the delivery of KQ Labs, a national accelerator for data-driven health science start-ups.
Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery System, has announced a collaboration with Cytiva.
